2024 annual financial data
XORTX Therapeutics Inc. 2024 Operating margin
XORTX Therapeutics Inc. 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -3,920,582 USD and net income was -3,154,259.5 USD.
Operating cash flow was -3,678,648 USD.
Get free XORTX Therapeutics Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -3,920,582 USD
- Net income
- -3,154,259.5 USD
- Operating cash flow
- -3,678,648 USD